Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hillstream Biopharma Inc (HILS)

Hillstream Biopharma Inc (HILS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hillstream Biopharma Inc 1200 Route 22 East Suite 2000 Bridgewater NJ 08807 USA

www.hillstreambio.com P: 908-955-3140

Description:

Hillstream BioPharma Inc. is a biotechnology company. It involved in developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers. Hillstream BioPharma Inc. is based in BRIDGEWATER, NJ.

Key Statistics

Overview:

Market Capitalization, $K 4,057
Enterprise Value, $K -2,453
Shares Outstanding, K 17,603
Annual Sales, $ 0 K
Annual Net Income, $ -8,470 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,340 K
EBIT, $ -8,970 K
EBITDA, $ -7,400 K
60-Month Beta 3.08
% of Insider Shareholders 30.24%
% of Institutional Shareholders 13.36%
Float, K 12,280
% Float 69.76%
Short Volume Ratio 0.46

Growth:

1-Year Return -72.64%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 08/11/23
Next Earnings Date 11/13/23
Earnings Per Share ttm -0.72
EPS Growth vs. Prev Qtr 30.43%
EPS Growth vs. Prev Year -14.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HILS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -188.44%
Return-on-Assets % -149.61%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.26
Book Value/Share 0.18
Interest Coverage -4.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar